Vaccine
. 2020 Aug 19;S0264-410X(20)31065-3.
doi: 10.1016/j.vaccine.2020.08.024. Online ahead of print.
The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies
John Paget 1 , Saverio Caini 2 , Ben Cowling 3 , Susanna Esposito 4 , Ann R Falsey 5 , Angela Gentile 6 , Jan Kyncl 7 , C McIntyre 8 , Richard Pitman 9 , Bruno Lina 10
Affiliations
- PMID: 32859436
- DOI: 10.1016/j.vaccine.2020.08.024
No abstract available
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [Saverio Caini, Ben Cowling, Susanna Esposito, Angela Gentile, Jan Kyncl, Richard Pitman and Bruno Lina declare no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. John Paget declares that Nivel has received unrestricted research grants from WHO, Sanofi Pasteur and the Foundation for Influenza Epidemiology. C Raina MacIntyre has received funding from Sanofi and Seqirus for influenza research in the past five years and has been on advisory boards for Sanofi, Seqirus and Pfizer for vaccines. Ann R Falsey has received research funding from Janssen, Pfizer, Merck Sharpe and Dohme and serves on the DSMB for Novavax].